ARE WE REALLY MEASURING ACCESS? SYSTEMATIC REVIEW OF ACCESS MEASURES TO MEDICINES IN BRAZIL

Author(s)

Araujo VE, Izidoro JB, Guerra-Junior Aa, Dias CZ, Ascef BO, Costa CM, Nascimento RC, Acurcio Fa, Alvares J
College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil

OBJECTIVES: : Access to medicines (ATM) is a key component in enabling and measuring the performance of health systems. This study aims to determine, through a systematic literature review, the profile of studies and the results of ATM's indicators in Brazil, according with the dimensions of access proposed by Penchansky and Thomas METHODS: A systematic review of observational studies was performed using articles located in PUBMED, CENTRAL, LILACS and Essential Medicines and Health Products Information Portal (WHO) databases (accessed July 2014), in manual search and in grey literature. The methodological quality was assessed using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies of NIH (National Institute of Health - USA). RESULTS: CONCLUSIONS: Most of ATM studies in Brazil evaluated it in the public sector, assessing essential drugs and using as a data source the users. The studies had focus on availability and no studies have assessed all dimensions of ATM. The access level was variable between studies. This review raises the need to develop a guideline to evaluate ATM that foment comparisons and evaluations of the health systems performance through the time.

Conference/Value in Health Info

2015-05, ISPOR 2015, Philadelphia, PA, USA

Value in Health, Vol. 18, No. 3 (May 2015)

Code

PHP48

Topic

Health Policy & Regulatory

Topic Subcategory

Health Disparities & Equity

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×